Considering the Rhogam shot?

There are definitely risks involved that your doctors won’t tell you. Please do your research.

Heres some studies on the risks:


Clinical Outcomes after Hepatitis C Infection from Contaminated Anti-D Immune Globulin

In the report by Kenny-Walsh and the Irish Hepatology Research Group (April 22 issue)1 on the outbreak of hepatitis C in Ireland in 1977 associated with the administration of anti-D immune globulin contaminated with hepatitis C virus (HCV),The New England Journal of Medicine 1999
http://www.nejm.org/doi/full/10.1056/NEJM199909023411013


Doctors to face disciplinary action over Irish hepatitis C scandal.

“The Irish Medical Council’s fitness to practice committee is to begin a disciplinary examination of the role of several doctors criticised by an official Tribunal of Inquiry into the country’s hepatitis C scandal. More than 1000 mothers were infected through contaminated anti-D immunoglobulin in the mid-1970s.” BMJ 1998
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2665410/pdf/9462311.pdf


Management of hypersensitivity reactions to anti-D immunoglobulin preparations.

We present three cases of suspected anti-D hypersensitivity clinically presenting as anaphylaxis and delayed transfusion-related reaction. We also propose a new algorithm for the investigations of such reaction. It relies on detailed history, cautious interpretation of skin tests, foetal Rh genotyping from maternal blood and, in some cases, anti-D challenges.
https://www.ncbi.nlm.nih.gov/m/pubmed/25066207


Neurodevelopmental disorders, maternal Rh-negativity, and Rho(D) immune globulins: a multi-center assessment.

“There were significant and comparable increases in maternal Rh-negativity among children with NDs (Clinic: A=24.2%), autism spectrum disorders (Clinic: A=28.3%, B=25.3%), and attention-deficit-disorder/attention-deficit-hyperactivity-disorder (Clinic: A=26.3%) observed at both clinics in comparison to both control groups (Clinic: A=12.1%, B=13.9%) employed. Children with NDs born post-2001 had a maternal Rh-negativity frequency (13.6%) similar to controls. This study associates TCR exposure with some NDs in children.”
https://www.ncbi.nlm.nih.gov/m/pubmed/18404135/


Potential drug interaction between Rho(D) immune globulin and live virus vaccine.

The immune globulin product has the potential to interfere with appropriate immune response to the vaccine. Here we describe our approach to identifying and following up on this often overlooked potential drug interaction.
https://www.ncbi.nlm.nih.gov/m/pubmed/25495973/


A prospective study of thimerosal-containing Rho(D)-immune globulin administration as a risk factor for autistic disorders.

Children with ASDs (28.30%) were significantly more likely (odds ratio 2.35, 95% confidence interval 1.17-4.52, p < 0.01) to have Rh-negative mothers than controls (14.36%). Each ASD patient’s mother was determined to have been administered a TCR during her pregnancy. The results provide insights into the potential role prenatal mercury exposure may play in some children with ASDs.
http://www.ncbi.nlm.nih.gov/pubmed/17674242


Reduced levels of mercury in first baby haircuts of autistic children.

The mothers in the autistic group had significantly higher levels of mercury exposure through Rho D immunoglobulin injections and amalgam fillings than control mothers.  In light of the biological plausibility of mercury’s role in neurodevelopmental disorders, the present study provides further insight into one possible mechanism by which early mercury exposures could increase the risk of autism.
http://www.ncbi.nlm.nih.gov/pubmed/12933322

0 Shares
Contact Us

Questions about vaccines?? Want good resources? Need support?! Send us an email and we'll get back to you.

Not readable? Change text. captcha txt
0
Close
X